Oracle’s waiting period to acquire Cerner has expired

Under the Hart-Scott-Rodino Act, the waiting period for Oracle to acquire Cerner expired at 11:59 p.m. EST on Feb. 22.

Advertisement

Oracle’s tender offer for Cerner shares remains under review. The tender offer was previously scheduled to expire at the end of the day Feb. 15, but Oracle extended it until March 16. Oracle said it anticipates extending the tender offer further to allow more time for review.

On Dec. 20, Oracle announced its agreement to acquire Cerner through an all-cash tender offer for $95 per share, or about $28.3 billion in equity value.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.